These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 21206549

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled study demonstrates sodium oxybate is effective for the treatment of excessive daytime sleepiness in narcolepsy.
    Xyrem International Study Group.
    J Clin Sleep Med; 2005 Oct 15; 1(4):391-7. PubMed ID: 17564408
    [Abstract] [Full Text] [Related]

  • 5. Further evidence supporting the use of sodium oxybate for the treatment of cataplexy: a double-blind, placebo-controlled study in 228 patients.
    Xyrem International Study Group.
    Sleep Med; 2005 Sep 15; 6(5):415-21. PubMed ID: 16099718
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Once-nightly sodium oxybate (FT218) improved symptoms of disrupted nighttime sleep in people with narcolepsy: a plain language summary.
    Roth T, Thorpy MJ, Kushida CA, Horsnell M, Gudeman J.
    J Comp Eff Res; 2023 Dec 15; 12(12):e230133. PubMed ID: 37971303
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications.
    Dauvilliers Y, Šonka K, Bogan RK, Partinen M, Del Rio Villegas R, Foldvary-Schaefer N, Skowronski R, Chen A, Black J, Skobieranda F, Thorpy MJ.
    CNS Drugs; 2022 Jun 15; 36(6):633-647. PubMed ID: 35635687
    [Abstract] [Full Text] [Related]

  • 12. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
    Prescrire Int; 2007 Jun 15; 16(89):98-101. PubMed ID: 17582923
    [Abstract] [Full Text] [Related]

  • 13. Sodium oxybate in the treatment of childhood narcolepsy-cataplexy: a retrospective study.
    Mansukhani MP, Kotagal S.
    Sleep Med; 2012 Jun 15; 13(6):606-10. PubMed ID: 22445591
    [Abstract] [Full Text] [Related]

  • 14. Impact of sodium oxybate, modafinil, and combination treatment on excessive daytime sleepiness in patients who have narcolepsy with or without cataplexy.
    Black J, Swick T, Bogan R, Lai C, Carter LP.
    Sleep Med; 2016 Aug 15; 24():57-62. PubMed ID: 27810187
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary.
    Rosenberg R, Braceras R, Macfadden W, Candler S, Black J, Ruoff C.
    Neurol Ther; 2023 Dec 15; 12(6):1805-1820. PubMed ID: 37755650
    [Abstract] [Full Text] [Related]

  • 18. Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy.
    Bogan RK, Foldvary-Schaefer N, Skowronski R, Chen A, Thorpy MJ.
    CNS Drugs; 2023 Apr 15; 37(4):323-335. PubMed ID: 36947322
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy.
    Kushida CA, Shapiro CM, Roth T, Thorpy MJ, Corser BC, Ajayi AO, Rosenberg R, Roy A, Seiden D, Dubow J, Dauvilliers Y.
    Sleep; 2022 Jun 13; 45(6):. PubMed ID: 34358324
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.